BlackRock Fund Advisors - ARGOS THERAPEUTICS INC ownership

ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 26 filers reported holding ARGOS THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of ARGOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$2,233,000
+13.6%
455,673
+15.2%
0.00%
Q3 2016$1,965,000
+13.8%
395,383
+40.4%
0.00%
Q2 2016$1,727,000
+838.6%
281,679
+880.1%
0.00%
Q1 2016$184,000
+155.6%
28,739
-7.6%
0.00%
Q4 2015$72,000
+12.5%
31,111
+134.1%
0.00%
Q3 2015$64,000
-31.2%
13,287
-2.6%
0.00%
Q2 2015$93,000
-13.1%
13,641
+13.7%
0.00%
Q1 2015$107,000
+174.4%
11,993
+208.7%
0.00%
Q4 2014$39,000
-96.0%
3,885
-96.0%
0.00%
Q1 2014$982,00098,1540.00%
Other shareholders
ARGOS THERAPEUTICS INC shareholders Q4 2014
NameSharesValueWeighting ↓
SANDERS MORRIS HARRIS LLC 241,512$1,201,0000.36%
WALL STREET ASSOCIATES 185,097$920,0000.31%
WASATCH ADVISORS LP 3,228,741$16,047,0000.24%
ALTRINSIC GLOBAL ADVISORS LLC 172,505$857,0000.03%
Dynamic Technology Lab Private Ltd 19,007$94,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 121,524$604,0000.01%
Alyeska Investment Group, L.P. 200,000$994,0000.01%
Acrospire Investment Management LLC 2,100$10,0000.01%
Alyeska Investment Group, L.P. 111,424$554,0000.01%
Advisor Group, Inc. 13,500$67,0000.00%
View complete list of ARGOS THERAPEUTICS INC shareholders